Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.
Oncotargets And Therapy
Sachdeva, Manavi M; Ngoi, Natalie Y L NYL; Lim, Diana D; Poon, Michelle L M MLM; Thian, Yee Liang YL; Lim, Yi Wan YW; Lim, Siew Eng SE; Tong, Pearl P; Lum, Jeffrey H Y JHY; Ng, Joseph J; Ilancheran, Arunachalam A; Domingo, Efren J EJ; Low, Jeffrey J H JJH; Tan, David S P DSP
Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.
Scientific Reports
Yu, Guoqin G; Hsu, Wan-Lun WL; Coghill, Anna E AE; Yu, Kelly J KJ; Wang, Cheng-Ping CP; Lou, Pei-Jen PJ; Liu, Zhiwei Z; Jones, Kristie K; Vogt, Aurelie A; Wang, Mingyi M; Mbulaiteye, Sam M SM; Chen, Hao-Hui HH; Boland, Joseph J; Yeager, Meredith M; Diehl, Scott R SR; Chen, Chien-Jen CJ; Hildesheim, Allan A; Goldstein, Alisa M AM